ImmuCell Corp. went public in 1987, and raised $5.5 million from investors for t
Date
8-7-1994
Pages
1F
Abstract
ImmuCell Corp. went public in 1987, and raised $5.5 million from investors for the creation and marketing of biotechnology products. The company currently makes $1 million annually from sales of First Defense, a veterinary product that prevents newborn cows from a lethal parasitic illness called scours. IT is working on a drug to protect people against a common form of severe diarrhea known as traveler's disease. Details.
Subjects
Biotechnology industries, ImmuCell Corp -- Portland
Recommended Citation
Gormley, John, "ImmuCell Corp. went public in 1987, and raised $5.5 million from investors for t" (1994). Maine News Index – Portland Press Herald. 14372.
https://digitalcommons.portlandlibrary.com/news_pph/14372
Source
Maine Sunday Telegram